Concepedia

Qinwen Zeng

QZ

Statistics

Publications

6

Citations

2.8K

H-Index

6

Active since

2000

Affiliations

Johns Hopkins Medicine(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Johns Hopkins University

Stanford University

Qinwen Zeng is an author at Johns Hopkins Medicine specializing in medicine, molecular oncology, and oncology.

Publications per year

2000–2011

6

Publications

6

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

Rajani Ravi, Bijoyesh Mookerjee, Zaver M. Bhujwalla et al. · PubMed · 2000 · 1.1K citations · Full text

, , +17

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α

Rajani Ravi, Bijoyesh Mookerjee, Zaver M. Bhujwalla et al. · Genes & Development · 2000 · 958 citations · Full text

, , +17

Lung Cancer Cell Lines Harboring <i>MET</i> Gene Amplification Are Dependent on Met for Growth and Survival

Bart Lutterbach, Qinwen Zeng, Lenora J. Davis et al. · Cancer Research · 2007 · 320 citations

, , +17

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB

Rajani Ravi, Gauri C. Bedi, Laura Engstrom et al. · Nature Cell Biology · 2001 · 310 citations

, , +14

MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor

Bo‐Sheng Pan, Grace K.Y. Chan, Mélissa Chénard et al. · Cancer Research · 2010 · 82 citations

, , +17

1–5 of 6